Global Spinal Needles Market Research Report Information by Type, by Application, by End User, and by Region Forecast till 2027

Description

List of Tables

Global Spinal Needles Market Research Report Information by Type (Atraumatic Needles, Directional Spinal Needles, Pencil-point Needles), by Application (Therapeutic, Diagnostic), by End User (Hospitals & Clinics, Diagnostic Centers, Research Laboratories, Specialty Centers), and by Region (Americas, Europe, Asia Pacific, Middle East and Africa) Forecast till 2027

Industry Overview

The global spinal needles market is expected to be valued at USD 356.74 million with a CAGR of 7.48% by the end of 2027. A spinal needle is a thin, hollow device designed to puncture the spinal canal for administering anesthesia or withdrawing cerebrospinal fluid. Its sharp, precise tip ensures accuracy during delicate procedures while reducing the risk of injury. Common uses include lumbar punctures, spinal anesthesia, and certain therapeutic interventions.

One of the main factors for this worldwide market development is the growth in ergonomic use of the spinal joints in therapeutic procedures, such as pain management, vertebroplasty, kyphoplasty, and spinal fusion. Surgeons increasingly favor pencil-point needles for anesthesia due to superior safety and effectiveness, driving higher adoption. There is constant progress in spinal needle design, various clinical trials, and the government, which is stepping up research investments. The predicted market for spinal directing devices is going to be strongly affected by this recent development of the sector, from open surgeries to minimally invasive surgeries.

Major Company Development

Medtronic plc is still working steadily to strengthen its presence worldwide in spinal surgery through its achievements. Among others, by acquiring Medicrea in France in November 2020, Medtronic has allowed itself to adopt cutting-edge AI-driven technologies for surgical planning, as well as implants and robotics, making it the first company to launch such solutions in the sector. The takeover of Titan Spine, an American company specializing in spinal implant surface technologies, gave the company new resources for technology and expertise and strengthened its position as the leading spinal implant manufacturer. Through these movements, Medtronic sends a message of its focus on technological innovation, company expansion, and the upgrading of healthcare related to the spine.

Key Players

Major players in the global spinal needles market are Stryker, Boston Scientific Corporation, B. Braun Melsungen AG, Medtronic Plc, Smiths Medical, Becton, Dickinson, and Company, EXELINT International, Co., Argon Medical, Myco Medical, and Cook Medical.

Report Attribute Details

Market Size 2020: USD 216.42 Million
Market Size 2027: USD 356.74 Million
CAGR (2021-2027): 7.48%
Base Year: 2020
Market Forecast Period: 2021-2027

Industry Segmentations

By Type: Atraumatic Needles - 7.33%, Directional Spinal Needles - 6.52%.
By Application: Therapeutic - 7.87%, Diagnostic - 6.61%.
By End User: Hospitals & Clinics - 8.39%, Diagnostic Centers - 7.54%.

Regional Analysis

The adoption of spinal needles in the Americas is going up significantly, and the main factor for this trend is the increasing incidence of degenerative spinal and neurological diseases. The U.S. is still the biggest contributor, with the occurrence of spinal and brain cancers every year that lead to the necessity of diagnostic services like lumbar punctures, in which thousands of new cases are registered annually. Valued at USD 67.54 million in 2020, North America remains the largest market due to high incidences of spinal disorders and the broad availability of medical devices. The market in Latin America, worth USD 20.54 million, is growing as awareness and demand for spinal diagnostic services increase.

The spinal needles market in Europe is mainly supported by the continent's aging population, which has a higher risk of neurodegenerative diseases. According to Eurostat, the demographic of people aged 65 and above is going to increase drastically, and this is going to be translated into a greater need for spinal diagnostics and treatments. Western Europe generated USD 42.53 million, while Eastern Europe contributed USD 14.68 million, underscoring a mix of mature markets and emerging opportunities.

The growth of Asia-Pacific is absolutely incomparable, and the main reasons for this are the huge demand for sophisticated healthcare services and the broadened research activities. Rising investments in healthcare infrastructure in both China and India not only fuel the two countries to become the region's largest markets but also elevate accessibility. With China at USD 9.98 million, India at USD 8.25 million, and Japan at USD 7.09 million, APAC is seeing rapid uptake fueled by healthcare advancements.

Middle East & Africa hold a smaller market share, opportunities are growing with increased investments in healthcare facilities. Countries in the Middle East are witnessing rising adoption due to improving infrastructure and greater healthcare expenditure. In Africa, partnerships with international medical device companies have improved access to spinal needles.

Product Code: MRFR/MED/0709-HCR

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 MARKET STRUCTURE
2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
- 3.6.1 BOTTOM-UP APPROACH
- 3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW
4.2 DRIVERS
- 4.2.1 INCREASING PREVALENCE OF SPINAL STENOSIS AND NEUROLOGICAL DISORDERS
- 4.2.2 RISING GERIATRIC POPULATION PRONE TO SPINAL DISORDERS
- 4.2.3 INCREASING APPLICATION OF SPINAL NEEDLES FOR SPINE SURGERIES
4.3 RESTRAINTS
- 4.3.1 SIDE EFFECTS AND COMPLICATIONS ASSOCIATED WITH SPINE SURGERY
- 4.3.2 STRINGENT GOVERNMENT REGULATIONS
4.4 OPPORTUNITIES
- 4.4.1 INCREASING NUMBER OF COLLABORATIONS, ACQUISITIONS, AND PRODUCT LAUNCHES

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS
- 5.1.1 R&D AND DESIGNING
- 5.1.2 MANUFACTURING
- 5.1.3 DISTRIBUTION, MARKETING, & SALES
- 5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
- 5.2.1 THREAT OF NEW ENTRANTS
- 5.2.2 BARGAINING POWER OF SUPPLIERS
- 5.2.3 THREAT OF SUBSTITUTES
- 5.2.4 BARGAINING POWER OF BUYERS
- 5.2.5 INTENSITY OF RIVALRY
5.3 COVID-19 IMPACT ANALYSIS
- 5.3.1 IMPACT ON SPINAL SURGERY
- 5.3.2 IMPACT ON SPINE SURGEONS
- 5.3.3 IMPACT ON CLINICAL TRIALS

6 GLOAL SPINAL NEEDLES MARKET, BY TYPE

6.1 INTRODUCTION
6.2 ATRAUMATIC NEEDLES
6.3 DIRECTIONAL SPINAL NEEDLES
6.4 PENCIL-POINT NEEDLES

7 GLOBAL SPINAL NEEDLES MARKET, BY APPLICATION

7.1 INTRODUCTION
7.2 THERAPEUTIC
7.3 DIAGNOSTIC

8 SPINAL NEEDLES MARKET, BY END USER

8.1 OVERVIEW
8.2 HOSPITALS & CLINICS
8.3 DIAGNOSTIC CENTERS
8.4 RESEARCH LABORATORIES
8.5 SPECIALTY CENTERS

9 GLOBAL SPINAL NEEDLES MARKET, BY REGION

9.1 OVERVIEW
9.2 AMERICAS
- 9.2.1 NORTH AMERICA
  - 9.2.1.1 US
  - 9.2.1.2 CANADA
- 9.2.2 LATIN AMERICA
9.3 EUROPE
- 9.3.1 WESTERN EUROPE
  - 9.3.1.1 GERMANY
  - 9.3.1.2 FRANCE
  - 9.3.1.3 UK
  - 9.3.1.4 ITALY
  - 9.3.1.5 SPAIN
  - 9.3.1.6 REST OF WESTERN EUROPE
- 9.3.2 EASTERN EUROPE
9.4 ASIA PACIFIC
- 9.4.1 CHINA
- 9.4.2 INDIA
- 9.4.3 JAPAN
- 9.4.4 SOUTH KOREA
- 9.4.5 AUSTRALIA
- 9.4.6 REST OF ASIA PACIFIC
9.5 MIDDLE EAST & AFRICA
- 9.5.1 MIDDLE EAST
- 9.5.2 AFRICA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL SPINAL NEEDLES MARKET
10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL SPINAL NEEDLES

MARKET 80

10.5 KEY DEVELOPMENT ANALYSIS
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 10.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
- 10.6.2 MERGER/ACQUISITION
- 10.6.3 EXPANSION/INVESTMENT
10.7 FINANCIAL MATRIX
- 10.7.1 SALES (USD MILLION) AND OPERATING PROFIT MARGIN (%), 2020
- 10.7.2 R&D EXPENDITURE (USD MILLION), 2020

11 COMPANY PROFILES

11.1 STRYKER CORPORATION
- 11.1.1 COMPANY OVERVIEW
- 11.1.2 FINANCIAL OVERVIEW
- 11.1.3 PRODUCTS OFFERED
- 11.1.4 KEY DEVELOPMENTS
- 11.1.5 SWOT ANALYSIS
- 11.1.6 KEY STRATEGIES
11.2 BOSTON SCIENTIFIC CORPORATION
- 11.2.1 COMPANY OVERVIEW
- 11.2.2 FINANCIAL OVERVIEW
- 11.2.3 PRODUCTS/SERVICES OFFERED
- 11.2.4 KEY DEVELOPMENTS
- 11.2.5 SWOT ANALYSIS
- 11.2.6 KEY STRATEGIES
11.3 B. BRAUN MELSUNGEN AG
- 11.3.1 COMPANY OVERVIEW
- 11.3.2 FINANCIAL OVERVIEW
- 11.3.3 PRODUCTS/SERVICES OFFERED
- 11.3.4 KEY DEVELOPMENTS
- 11.3.5 SWOT ANALYSIS
- 11.3.6 KEY STRATEGIES
11.4 MEDTRONIC PLC
- 11.4.1 COMPANY OVERVIEW
- 11.4.2 FINANCIAL OVERVIEW
- 11.4.3 PRODUCTS/SERVICES OFFERED
- 11.4.4 KEY DEVELOPMENTS
- 11.4.5 SWOT ANALYSIS
- 11.4.6 KEY STRATEGIES
11.5 SMITHS MEDICAL
- 11.5.1 COMPANY OVERVIEW
- 11.5.2 FINANCIAL OVERVIEW
- 11.5.3 PRODUCTS/SERVICES OFFERED
- 11.5.4 KEY DEVELOPMENTS
- 11.5.5 SWOT ANALYSIS
- 11.5.6 KEY STRATEGIES
11.6 BECTON, DICKINSON, AND COMPANY
- 11.6.1 COMPANY OVERVIEW
- 11.6.2 FINANCIAL OVERVIEW
- 11.6.3 PRODUCTS OFFERED
- 11.6.4 KEY DEVELOPMENTS
- 11.6.5 SWOT ANALYSIS
- 11.6.6 KEY STRATEGIES
11.7 EXELINT INTERNATIONAL, CO.
- 11.7.1 COMPANY OVERVIEW
- 11.7.2 FINANCIAL OVERVIEW
- 11.7.3 PRODUCTS OFFERED
- 11.7.4 KEY DEVELOPMENTS
- 11.7.5 SWOT ANALYSIS
- 11.7.6 KEY STRATEGIES
11.8 ARGON MEDICAL
- 11.8.1 COMPANY OVERVIEW
- 11.8.2 FINANCIAL OVERVIEW
- 11.8.3 PRODUCTS OFFERED
- 11.8.4 KEY DEVELOPMENTS
- 11.8.5 SWOT ANALYSIS
- 11.8.6 KEY STRATEGIES
11.9 MYCO MEDICAL
- 11.9.1 COMPANY OVERVIEW
- 11.9.2 FINANCIAL OVERVIEW
- 11.9.3 PRODUCTS OFFERED
- 11.9.4 KEY DEVELOPMENTS
- 11.9.5 SWOT ANALYSIS
- 11.9.6 KEY STRATEGIES
11.10 COOK MEDICAL
- 11.10.1 COMPANY OVERVIEW
- 11.10.2 FINANCIAL OVERVIEW
- 11.10.3 PRODUCTS OFFERED
- 11.10.4 KEY DEVELOPMENTS
- 11.10.5 SWOT ANALYSIS
- 11.10.6 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES
12.2 RELATED REPORTS